$CLCS
Cell Source, Inc.

2023 Q2 Form 10-Q Financial Statement

#000149315223033011 Filed on September 19, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $540.0K $464.4K
YoY Change 16.29% -26.0%
% of Gross Profit
Research & Development $370.0K $555.0K
YoY Change -33.33% 51.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $905.5K $1.034M
YoY Change -12.42% 3.9%
Operating Profit -$905.5K -$1.034M
YoY Change -12.42% 3.9%
Interest Expense -$380.0K $63.31K
YoY Change -700.19% -119.91%
% of Operating Profit
Other Income/Expense, Net -$336.1K -$251.7K
YoY Change 33.54% -20.85%
Pretax Income -$1.240M -$1.286M
YoY Change -3.55% -2.1%
Income Tax
% Of Pretax Income
Net Earnings -$1.242M -$1.286M
YoY Change -3.42% -2.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.04 -$0.04
Diluted Earnings Per Share -$0.04 -$37.33K
COMMON SHARES
Basic Shares Outstanding 37.21M shares 34.44M shares
Diluted Shares Outstanding 37.21M shares 34.44M shares

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.00K $2.600K
YoY Change 669.23% -96.82%
Cash & Equivalents $21.99K $2.597K
Short-Term Investments
Other Short-Term Assets $16.34K $16.13K
YoY Change 1.26% -92.78%
Inventory
Prepaid Expenses $324.0K $25.91K
Receivables
Other Receivables
Total Short-Term Assets $360.0K $44.64K
YoY Change 706.45% -85.37%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.329K $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $360.0K $44.64K
Total Long-Term Assets $2.329K $0.00
Total Assets $362.3K $44.64K
YoY Change 711.67% -85.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $927.8K $382.0K
YoY Change 142.87% 12.36%
Accrued Expenses $4.370M $1.501M
YoY Change 191.15% -46.89%
Deferred Revenue
YoY Change
Short-Term Debt $680.0K $750.5K
YoY Change -9.39% -7.73%
Long-Term Debt Due $1.800M $806.7K
YoY Change 123.12% -86.18%
Total Short-Term Liabilities $15.31M $10.81M
YoY Change 41.61% 4.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $15.31M $10.81M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $15.31M $10.81M
YoY Change 41.59% 4.6%
SHAREHOLDERS EQUITY
Retained Earnings -$39.28M -$33.76M
YoY Change 16.36% 18.26%
Common Stock $38.16K $35.24K
YoY Change 8.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$14.95M -$10.77M
YoY Change
Total Liabilities & Shareholders Equity $362.3K $44.64K
YoY Change 711.67% -85.53%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.242M -$1.286M
YoY Change -3.42% -2.1%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.040M -$300.6K
YoY Change 246.0% -73.71%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 920.0K 171.2K
YoY Change 437.41% -84.79%
NET CHANGE
Cash From Operating Activities -1.040M -300.6K
Cash From Investing Activities
Cash From Financing Activities 920.0K 171.2K
Net Change In Cash -120.0K -129.4K
YoY Change -7.26% 623.25%
FREE CASH FLOW
Cash From Operating Activities -$1.040M -$300.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001569340
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CLCS Common Stock Based Compensation
CommonStockBasedCompensation
usd
CLCS Increase Decrease In Accrued Expenses Related Parties
IncreaseDecreaseInAccruedExpensesRelatedParties
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CLCS Financing Of Directors And Officers Insurance
FinancingOfDirectorsAndOfficersInsurance
usd
CLCS Conversion Of Accrued Expenses Into Note Principal
ConversionOfAccruedExpensesIntoNotePrincipal
usd
CLCS Warrants Issued In Satisfaction Of Accrued Warrant Obligation
WarrantsIssuedInSatisfactionOfAccruedWarrantObligation
usd
CLCS Extinguishment Of Note Payable For Common Stock
ExtinguishmentOfNotePayableForCommonStock
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55413
dei Entity Registrant Name
EntityRegistrantName
Cell Source, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0379665
dei Entity Address Address Line1
EntityAddressAddressLine1
57 West 57th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
dei City Area Code
CityAreaCode
(646)
dei Local Phone Number
LocalPhoneNumber
416-7896
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38195617 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21993 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
222665 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
324000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
164175 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
16336 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
23005 usd
CY2023Q2 us-gaap Assets
Assets
362329 usd
CY2022Q4 us-gaap Assets
Assets
409845 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
927800 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
680325 usd
CY2023Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
855788 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
849898 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
321500 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
1479 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
5217 usd
CY2023Q2 us-gaap Liabilities
Liabilities
15308088 usd
CY2022Q4 us-gaap Liabilities
Liabilities
13043740 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38163385 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38163385 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36081758 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36081758 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
38163 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
36082 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24293583 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23674354 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39279347 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36346176 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-14945759 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12633895 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
362329 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
409845 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
539877 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
464367 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1616926 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1038034 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
905465 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1033877 usd
us-gaap Operating Expenses
OperatingExpenses
2321014 usd
us-gaap Operating Expenses
OperatingExpenses
2086549 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-905465 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1033877 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2321014 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2086549 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
41920 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
41920 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-336139 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-251717 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-612157 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-491620 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1241604 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1285594 usd
us-gaap Net Income Loss
NetIncomeLoss
-2933171 usd
us-gaap Net Income Loss
NetIncomeLoss
-2578169 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
300849 usd
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
244971 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
598366 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
569888 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1542453 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1530565 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3531537 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3148057 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37213515 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37213515 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34438057 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34438057 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37137064 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37137064 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34419213 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34419213 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-12633895 usd
CY2023Q1 CLCS Conversion Of Convertible Notes Payable And Accrued Interest Into Series C Convertible Preferred Stock And Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCConvertiblePreferredStockAndCommonStock
52060 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-297517 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
21202 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
330000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1691567 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-14219717 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-300849 usd
CY2023Q2 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
602102 usd
CY2023Q2 CLCS Stock Issued During Issuance Of Common Stock In Connection With Extinguishment Of Note Payable
StockIssuedDuringIssuanceOfCommonStockInConnectionWithExtinguishmentOfNotePayable
58080 usd
CY2023Q2 CLCS Warrants Issued In Satisfaction Of Accrued Interest
WarrantsIssuedInSatisfactionOfAccruedInterest
40167 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
75462 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
40600 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1241604 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-14945759 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-9826135 usd
CY2022Q1 CLCS Conversion Of Convertible Notes Payable And Accrued Interest Into Series C Convertible Preferred Stock And Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCConvertiblePreferredStockAndCommonStock
1433095 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-324917 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
8043 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
5372 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1292575 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-9997117 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-9997117 usd
CY2022Q2 CLCS Conversion Of Convertible Notes Payable And Accrued Interest Into Series C Convertible Preferred Stock And Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCConvertiblePreferredStockAndCommonStock
114473 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-244971 usd
CY2022Q2 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
597431 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
49219 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1285594 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-10766559 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-10766559 usd
us-gaap Net Income Loss
NetIncomeLoss
-2933171 usd
us-gaap Net Income Loss
NetIncomeLoss
-2578169 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
41920 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
281025 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
131493 usd
CLCS Noncash Interest Expense Warrants
NoncashInterestExpenseWarrants
18859 usd
CLCS Noncash Interest Expense Warrants
NoncashInterestExpenseWarrants
-63267 usd
CLCS Warrants Based Compensation
WarrantsBasedCompensation
39578 usd
CLCS Warrants Based Compensation
WarrantsBasedCompensation
5034 usd
CLCS Common Stock Based Compensation
CommonStockBasedCompensation
339438 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-161675 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-177839 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-6669 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-790 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
247475 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
158968 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
153994 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
403916 usd
CLCS Increase Decrease In Accrued Expenses Related Parties
IncreaseDecreaseInAccruedExpensesRelatedParties
29000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
82279 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-44729 usd
CLCS Increase Decrease In Accrued Interest Related Parties
IncreaseDecreaseInAccruedInterestRelatedParties
309711 usd
CLCS Increase Decrease In Accrued Interest Related Parties
IncreaseDecreaseInAccruedInterestRelatedParties
320361 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-2526 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
32476 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1345632 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1328754 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
794960 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
245000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
350000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
168094 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
146912 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
27926 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1144960 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1238256 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-200672 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-90498 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
222665 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
93095 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21993 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2597 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
949 usd
CLCS Accrual Of Earned Preferred Stock Dividends
AccrualOfEarnedPreferredStockDividends
-598366 usd
CLCS Accrual Of Earned Preferred Stock Dividends
AccrualOfEarnedPreferredStockDividends
-569888 usd
us-gaap Stock Issued1
StockIssued1
602102 usd
us-gaap Stock Issued1
StockIssued1
597431 usd
CLCS Financing Of Directors And Officers Insurance
FinancingOfDirectorsAndOfficersInsurance
321500 usd
us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
one vote per share
CY2023Q2 CLCS Share Based Compensation Included In Stockholders Deficiency
ShareBasedCompensationIncludedInStockholdersDeficiency
40600 usd
CY2023Q2 CLCS Accrued Compensation
AccruedCompensation
73 usd
CLCS Share Based Compensation Included In Stockholders Deficiency
ShareBasedCompensationIncludedInStockholdersDeficiency
40600 usd
CLCS Accrued Compensation
AccruedCompensation
-1022 usd
CLCS Conversion Of Accrued Expenses Into Note Principal
ConversionOfAccruedExpensesIntoNotePrincipal
413018 usd
CLCS Accrual Of Warrant Obligations In Connection With Issuance Of Notes Payable
AccrualOfWarrantObligationsInConnectionWithIssuanceOfNotesPayable
40167 usd
CLCS Accrual Of Warrant Obligations In Connection With Issuance Of Notes Payable
AccrualOfWarrantObligationsInConnectionWithIssuanceOfNotesPayable
114727 usd
CLCS Warrants Issued In Satisfaction Of Accrued Warrant Obligation
WarrantsIssuedInSatisfactionOfAccruedWarrantObligation
-40167 usd
CLCS Issuance Of Warrants In Connection With Issuance Of Notes Payable
IssuanceOfWarrantsInConnectionWithIssuanceOfNotesPayable
96664 usd
CLCS Issuance Of Warrants In Connection With Issuance Of Notes Payable
IssuanceOfWarrantsInConnectionWithIssuanceOfNotesPayable
57262 usd
CLCS Conversion Of Convertible Notes Payable And Accrued Interest Into Series C Preferred Stock And Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCPreferredStockAndCommonStock
52060 usd
CLCS Conversion Of Convertible Notes Payable And Accrued Interest Into Series C Preferred Stock And Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCPreferredStockAndCommonStock
1547568 usd
CLCS Extinguishment Of Note Payable For Common Stock
ExtinguishmentOfNotePayableForCommonStock
58080 usd
us-gaap Net Income Loss
NetIncomeLoss
-2933000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1346000 usd
CY2023Q2 CLCS Working Capital Surplus Deficiency
WorkingCapitalSurplusDeficiency
14946000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39279000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42906114 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
38540367 shares
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
563920 usd
CY2023Q1 CLCS Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Accrual Of Warrant Obligation
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccrualOfWarrantObligation
40167 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-47226 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
556861 usd
CY2023Q2 CLCS Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Accrual Of Common Stock Obligation
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccrualOfCommonStockObligation
9438 usd
CY2023Q2 CLCS Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Warrant Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisWarrantIssues
-40167 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
27345 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
553477 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
463650 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
33197 usd
CY2022Q1 CLCS Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Accrual Of Warrant Obligation
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccrualOfWarrantObligation
114727 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
611574 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
29732 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
641306 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
183095 shares
CY2022 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
154495 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
60421 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
50983 usd
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.33
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.33
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CLCS Accrued Compensation
AccruedCompensation
-338 usd
CY2019Q4 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
267680 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
146912 usd
CY2023Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
106000 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
360000 shares

Files In Submission

Name View Source Status
0001493152-23-033011-index-headers.html Edgar Link pending
0001493152-23-033011-index.html Edgar Link pending
0001493152-23-033011.txt Edgar Link pending
0001493152-23-033011-xbrl.zip Edgar Link pending
clcs-20230630.xsd Edgar Link pending
ex-31.htm Edgar Link pending
ex-32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
clcs-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
clcs-20230630_cal.xml Edgar Link unprocessable
clcs-20230630_def.xml Edgar Link unprocessable
clcs-20230630_lab.xml Edgar Link unprocessable